Docality.com Logo
 
Dr. Charles  Boudreaux  Md image

Dr. Charles Boudreaux Md

3315 Watt Ave
Sacramento CA 95821
916 816-6800
Medical School: University Of California, San Francisco School Of Medicine - 1991
Accepts Medicare: Yes
Participates In eRX: No
Participates In PQRS: Yes
Participates In EHR: No
License #: G76780
NPI: 1962495325
Taxonomy Codes:
207L00000X

Request Appointment Information

Awards & Recognitions

About Us

Practice Philosophy

Conditions

Dr. Charles Boudreaux is associated with these group practices

Procedure Pricing

HCPCS Code Description Average Price Average Price
Allowed By Medicare
HCPCS Code:00562 Description:Anesth hrt surg w/pmp age 1+ Average Price:$3,233.00 Average Price Allowed
By Medicare:
$765.69
HCPCS Code:00567 Description:Anesth cabg w/pump Average Price:$2,914.36 Average Price Allowed
By Medicare:
$688.15
HCPCS Code:01926 Description:Anes tx interv rad hrt/cran Average Price:$2,085.23 Average Price Allowed
By Medicare:
$480.58
HCPCS Code:00840 Description:Anesth surg lower abdomen Average Price:$1,446.60 Average Price Allowed
By Medicare:
$341.25
HCPCS Code:93503 Description:Insert/place heart catheter Average Price:$900.00 Average Price Allowed
By Medicare:
$134.52
HCPCS Code:00104 Description:Anesth electroshock Average Price:$475.05 Average Price Allowed
By Medicare:
$112.51
HCPCS Code:36556 Description:Insert non-tunnel cv cath Average Price:$360.00 Average Price Allowed
By Medicare:
$122.08
HCPCS Code:36620 Description:Insertion catheter artery Average Price:$270.00 Average Price Allowed
By Medicare:
$51.55
HCPCS Code:93313 Description:Echo transesophageal Average Price:$180.00 Average Price Allowed
By Medicare:
$42.17

HCPCS Code Definitions

36556
Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older
93503
Insertion and placement of flow directed catheter (eg, Swan-Ganz) for monitoring purposes
36620
Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous
93313
Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); placement of transesophageal probe only

Medical Malpractice Cases

None Found

Medical Board Sanctions

None Found

Referrals

NPI
Doctor Name
Specialty
Count
1619065513
Psychiatry
820
1134291206
Cardiovascular Disease (Cardiology)
172
1437122538
Cardiovascular Disease (Cardiology)
87
1003938192
Cardiovascular Disease (Cardiology)
84
1437147923
Cardiac Surgery
81
1154342343
Nephrology
68
1457349938
Cardiovascular Disease (Cardiology)
63
1134174170
Diagnostic Radiology
55
1811984859
Diagnostic Radiology
46
1609862333
Cardiovascular Disease (Cardiology)
44
*These referrals represent the top 10 that Dr. Boudreaux has made to other doctors

Publications

Spiroplasma found in the eyes of scrapie affected sheep. - Veterinary ophthalmology
Scrapie, a transmissible spongiform encephalopathy (TSE) occurring naturally in sheep, characteristically shows a severe retinopathy that is well developed in the terminal phases of the disease. In this study, we set out to demonstrate similar retinal changes in our ruminant spiroplasmosis TSE model.The eyes from deer, sheep, and goats that were inoculated intracranially with the laboratory strain of spiroplasma (suckling mouse cataract [SMCA] strain of Spiroplasma mirum) or with Spiroplasma sp. isolated from the brains affected with scrapie or with chronic wasting disease were examined by light microscopy for pathologic changes and by immunocytochemistry for distribution of spiroplasma antigen. The eyes were also obtained from a research flock of sheep with terminal scrapie, from which the intraocular tissues were submitted aseptically for culture assay in M1D broth or as explants on bovine corneal endothelia (BCE).The eyes from the spiroplasmosis ruminant models showed retinopathy remarkably similar to eye lesions seen in sheep with scrapie. The spiroplasma antigen accrued in the ruminant model eye tissues, particularly in the retina, the vitreous humor, and the corneal endothelia. A Spiroplasma sp. grew out of the scrapie-affected eyes both in the M1D broth and in the BCE cultures but did not expand. These new spiroplasma isolates differed immunologically from SMCA.These data showed a clear association of spiroplasma with scrapie suggesting that these bacteria have a role in the pathogenesis of TSE and that the eye should be a research focus for future studies of TSE.© 2011 American College of Veterinary Ophthalmologists.
Effects of cecropin B transgene expression on Mannheimia haemolytica serotype 1 colonization of the nasal mucosa of calves. - American journal of veterinary research
To express a cecropin B transgene on bovine nasal mucosa and determine the effect on Mannheimia haemolytica serotype 1 (S1) colonization.27 crossbred beef calves.The antibacterial efficacy of cecropin B against M. haemolytica S1 was first determined by measuring its minimum inhibitory concentration (MIC). The peptide was also diluted in pooled bovine nasal secretions, and its antibacterial activity was evaluated. The nasal passages of 16 calves were aerosolized with 25, 50, or 100 microg of plasmid DNA/nostril, whereas 11 control calves were aerosolized with only the transfection reagent. In 2 of the experiments, 12 treated and 8 control calves were exposed intranasally with an aerosol of M. haemolytica S1. Nasal swab specimens and secretions were collected and analyzed by use of polymerase chain reaction (PCR), real-time PCR, real-time reverse-transcriptase PCR, ELISA, and bacterial culture.In vitro, cecropin B inhibited M. haemolytica S1 at an MIC of 2 microg/mL and its antibacterial activity was not affected by proteolytic activity in nasal secretions. Cecropin B transgene expression was detected in calves transfected with 50 or 100 microg of DNA/nostril. Antibacterial activity against M. haemolytica S1 was observed in all calves transfected with 100 microg of DNA/nostril but in only 2 of the 4 calves transfected with 50 microg of DNA/nostril.In vitro, cecropin B has an effective antibacterial activity against M. haemolytica S1 and can prevent colonization of the nasal mucosa after transfection of a vector expressing cecropin B in vivo.
Kinetics of antibody response to Ehrlichia canis immunoreactive proteins. - Infection and immunity
Immunoreactive proteins of Ehrlichia canis and Ehrlichia chaffeensis that have been characterized include a family of 28-kDa major outer membrane proteins (p28) and two large antigenically divergent surface glycoprotein orthologs. We previously demonstrated that recombinant E. canis p28 and the 140- and 200-kDa glycoproteins gp140 and gp200, respectively, react strongly with serum antibodies from suspect canine ehrlichiosis cases that were positive for E. canis by immunofluorescent antibody test and in various phases of acute or chronic infection (J. Clin. Microbiol. 39:315-322, 2001). The kinetics of the antibody response to these potentially important vaccine and immunodiagnostic candidates is not known. Acute-phase serum antibody responses to whole-cell E. canis lysates and recombinant p28, gp140, and gp200 were monitored for 6 weeks in dogs experimentally infected with E. canis. Irrespective of the inoculation route, a T-helper 1-type response was elicited to E. canis antigens consisting of immunoglobulin G2 antibodies exclusively in both acute and convalescent phases in most dogs. Analysis of immuoreactive antigens for peak intensity and relative quantity identified major immunoreactive E. canis antigens recognized early in the infection as the 19-, 37-, 75-, and 140-kDa proteins. Later in infection, additional major immunoreactive E. canis proteins were identified, including the 28-, 47-, and 95-kDa proteins and the recently identified 200-kDa glycoprotein. All dogs had developed antibody against the recombinant gp140, gp200, and p28 in the convalescent phase. Immunoreactivity and antibody response kinetics suggest that major immunoreactive proteins identified are immunodominant, but early recognition suggests increased dominance by some antigens.

Map & Directions

3315 Watt Ave Sacramento, CA 95821
View Directions In Google Maps

Nearby Doctors

2288 Auburn Blvd Suite 200
Sacramento, CA 95821
916 643-3377
2821 Eastern Avenue Suite #2
Sacramento, CA 95821
916 837-7459
2288 Auburn Ave
Sacramento, CA 95821
916 297-7229
2288 Auburn Blvd Suite 106
Sacramento, CA 95821
916 688-8338
3960 El Camino Ave Ste 4
Sacramento, CA 95821
916 838-8217
3315 Watt Ave
Sacramento, CA 95821
916 816-6800
3315 Watt Avenue Case Medical Group
Sacramento, CA 95821
916 810-0777
3517 Marconi Ave Suite 102
Sacramento, CA 95821
916 855-5433
3315 Watt Ave
Sacramento, CA 95821
916 816-6800
3315 Watt Ave
Sacramento, CA 95821
916 816-6800